McKnight’s Senior Living April 16, 2024
Turkey-based digital health startup h2o therapeutics announced its new Apple Watch-enabled freezing of gait-cueing feature, dubbed Foggy, has received Food and Drug Administration listing as a Class II medical device and is available via prescription. The feature is designed for people living with Parkinson’s disease.
Parkinson’s affects millions worldwide, including many long-term care residents. A 2015 analysis of Medicare data published in the journal Neurology found that 25% of people with Parkinson’s resided in a long-term care facility such as a nursing home or assisted living community. The ailment presents unique challenges to both caregivers and individuals. Freezing of gait is when someone has temporary episodes of an inability to step forward. Such episodes often cause falls to occur.
Foggy...
Today's Sponsors
Today's Sponsor